Form 4 for IDXX Idexx Laboratories
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0000874716-26-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $505.53 | +197 | 7,138 | +3% | +$99.6K |
| D | 2026-03-05 | 2026-03-03 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | — | -197 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | M | A | 197 | $505.53 | 7,137.65 | D | — | — | |
| 2 | Derivative | Incentive Stock Option (right-to-buy) | 2026-03-03 | M | D | 197 | — | 0 | D | $505.53 · — to 2032-02-13 | 197 Common Stock | (F2) Not applicable. (F1) Grant of option to buy shares of Issuer common stock that vested on February 14, 2026. |